Table 1.
AM (%) |
MAC (%) |
Neutrophils (%) |
CD11c+CD11b-F4/80-(%) | CD11c+CD11b+F4/80-(%) | CD4+ T (%) |
CD8+ T (%) |
|
---|---|---|---|---|---|---|---|
WT | 40.63 ± 14.64 | 3.28 ± 1.03 | 15.05 ± 7.01 | 2.20 ± 0.73 | 1.59 ± 0.27 | 15.78 ± 5.28 | 6.14 ± 3.33 |
PKD1mKO | 41.77 ± 5.30 | 3.87 ± 1.36 | 15.39 ± 2.91 | 2.07 ± 0.40 | 1.80 ± 0.52 | 13.07 ± 3.52 | 3.88 ± 1.07 |
WT (n = 4) and PKD1mKO (n = 5) were exposed to S. rectivirgula (100 μg) three times per week for 3 weeks and analyzed 72 hours after the last exposure. The frequency of alveolar macrophages (AM: CD11c+F4/80+), macrophages (MAC: CD11b+F4/80+CD11c-), neutrophils (CD11b+Gr1+F4/80-), CD11c+CD11b-F4/80- cells, CD11c+CD11b+F4/80- cells, CD4+ T cells (CD4+βTcR+), and CD8+ T cells (CD8+βTcR+) in BAL cells were measured by flow cytometry followed by analysis using FlowJo software as described in Materials and Methods and expressed as % of CD45+ cells. Values are given as mean ± SD of each group. Gating strategy is shown in Supplementary Figure 3A . Significance was determined by two-tailed Student’s t-test.